Phase IIb study of SST-6007 for treatment of female sexual arousal disorder.

Trial Profile

Phase IIb study of SST-6007 for treatment of female sexual arousal disorder.

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Apr 2018

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Apr 2018 According to a Dare Bioscience media release, the company intends to communicate with the U.S. Food and Drug Administration in mid-2018 regarding this Phase 2b study. Company intends to initiate the study in Q4, 2018.
    • 19 Feb 2018 New trial record
    • 12 Feb 2018 According to the Dare Bioscience media release, company anticipates to start this trial in second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top